For decades, University of Minnesota Masonic Children's Hospital has led the field in providing compassionate, innovative care to young patients in need of blood and marrow transplant (BMT).
Our program is a long-time national leader in BMT research and care. We reported the world’s first successful BMT in 1968, and since then our program continues to thrive as one of the most respected research and treatment programs in the world.
Our researchers also have led the field with stem cell therapy research and immunotherapy. We care for patients with cancers, including leukemia, lymphoma, and specialize in caring for patients with rare, devastating diseases like epidermolysis bullosa, Hurler syndrome and Fanconi anemia.
We offer an approach to treatment that puts your child and family at the center of our comprehensive care, therapies, and commitment from our team. BMT patients have complex medical needs requiring the attention of many medical sub-specialists. Our multidisciplinary team of healthcare professionals focus on the unique needs of BMT patients and range from oncologists and hematologists, to nurses, social workers, pharmacists and child family life specialists.
Meet our entire care team and learn more about our program and the conditions we treat.